Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Liver Cancer|October 12, 2019
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score AnalysisDominik Bettinger, David J Pinato, Michael Schultheiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib StudyDavid J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2026
Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world dataClaudia Campani, Ju Hyun Shim, Mohamed Bouattour, et al.
Hepatology Communications|April 28, 2022
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCCRohini Sharma, Anjana Pillai, Thomas Urban Marron, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2026
Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinomaAnne Victoire Odent, Claudia Campani, Mohamed Bouattour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with CancerAyumi Hashimoto, Debashis Sarker, Vikash Reebye, et al.
Langenbeck'S Archives of Surgery|September 13, 2024
The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic reviewVictor Lopez-Lopez, Fabian Kalt, Jian-Hong Zhong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 20, 2022
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 27, 2025
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/BevacizumabClaudia Campani, Clelia Galvanin, Ju Hyun Shim, et al.
Hepatology International|April 3, 2023
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Pageof 17